myelodysplastic syndromes (MDS) | Page 152 | Aplastic Anemia & MDS International Foundation Return to top.

myelodysplastic syndromes (MDS)

Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis

Author(s): 
Zhao Y, Fei C, Zhang X, Zhang Y, Guo J, Gu S, Li X, Chang C
Primary Author: 
Zhao Y
Journal Title: 
Tumour Biol
Original Publication Date: 
Sep 2012

The identification of epigenetically inactivated tumor suppressor genes may shed additional light on the pathogenesis of

Bone Marrow Disease(s): 

Reduced ribosomal RNA expression and increased ribosomal DNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes

Author(s): 
Raval A, Sridhar KJ, Patel S, Turnbull BB, Greenberg PL, Mitchell BS
Primary Author: 
Raval A
Journal Title: 
Blood
Original Publication Date: 
Oct 2012

Bone Marrow Disease(s): 

Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update

Author(s): 
Joeckel TE, Lübbert M
Primary Author: 
Joeckel TE
Journal Title: 
Semin Hematol
Original Publication Date: 
Oct 2012

Patients with

Bone Marrow Disease(s): 
Share with addtoany.com.